Australian Clinical Labs Ltd (ASX:ACL)

Last updated

Position & Order Advice

    [dvmd_table_maker tbl_column_header_count=”0″ _builder_version=”4.14.5″ _module_preset=”default” width_tablet=”” width_phone=”” width_last_edited=”on|phone” max_width=”100%” module_alignment=”left” hover_enabled=”0″ global_colors_info=”{}” disabled_on=”on|on|on” disabled=”on” sticky_enabled=”0″][dvmd_table_maker_item col_label=”Name” col_content=”Date
    Buy Limit Price ($)
    Open Position
    Stop Loss ($)
    Target Price ($)” col_tcell_cell_align_horz=”right” _builder_version=”4.10.1″ _module_preset=”default” global_colors_info=”{}”][/dvmd_table_maker_item][dvmd_table_maker_item col_label=”Values” col_content=”15-Sep-21
    4.40
    1,000
    4.50
    6.75″ col_tcell_cell_align_horz=”right” _builder_version=”4.10.1″ _module_preset=”default” global_colors_info=”{}”][/dvmd_table_maker_item][/dvmd_table_maker]

    Exit remaining shares

    by | Feb 1, 2022

    With the number of covid-19 cases in NSW and around the country starting to drop off, the ACL share price is beginning to retreat. So it is time to sell the remaining shares and lock in profits before earnings are reported in the next few weeks. The company has been a...

    Open Position Trade Blotter

    All positions use a hypothetical position size and is not a advice on the recommended trade size. This is done to calculate the dividend and franking credits.

     

     Closed Positions Trade History

    All positions use a hypothetical position size and is not a advice on the recommended trade size. This is done to calculate the dividend and franking credits.

    [dvmd_table_maker tbl_row_header_count=”0″ tbl_responsive_break_by=”row” tbl_stripes_active=”on” tbl_stripes_order=”odd” tbl_chead_cell_align_horz=”center” _builder_version=”4.14.5″ _module_preset=”default” tbl_chead_text_font=”|||on|||||” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][dvmd_table_maker_item col_label=”Date” col_content=”Date
    15-Sep-21
    22-Dec-21
    01-Feb-22″ col_tcell_cell_align_horz=”right” _builder_version=”4.14.5″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/dvmd_table_maker_item][dvmd_table_maker_item col_label=”B/S” col_content=”B/S
    BUY
    SELL
    SELL” col_tcell_cell_align_horz=”right” _builder_version=”4.14.5″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/dvmd_table_maker_item][dvmd_table_maker_item col_label=”Qty” col_content=”Qty
    2,000
    1,000
    1,000″ col_icon_type=”=||divi||400″ col_tcell_cell_align_horz=”right” _builder_version=”4.14.5″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/dvmd_table_maker_item][dvmd_table_maker_item col_label=”Price ($)” col_content=”Price ($)
    4.40
    5.95
    5.07″ col_tcell_cell_align_horz=”right” _builder_version=”4.14.5″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/dvmd_table_maker_item][dvmd_table_maker_item col_label=”Total ($)” col_content=”Total ($)
    8,800.00
    5,950.00
    5,070.00″ col_tcell_cell_align_horz=”right” _builder_version=”4.14.5″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/dvmd_table_maker_item][dvmd_table_maker_item col_label=”Notes” col_content=”Notes” _builder_version=”4.10.1″ _module_preset=”default” global_colors_info=”{}”][/dvmd_table_maker_item][/dvmd_table_maker]
    [dvmd_table_maker tbl_column_header_count=”0″ disabled_on=”off|off|off” _builder_version=”4.14.5″ _module_preset=”default” width_tablet=”” width_phone=”” width_last_edited=”on|desktop” max_width=”100%” module_alignment=”right” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][dvmd_table_maker_item col_label=”Name” col_content=”Dividends ($)
    Franking Cr. ($)
    Capital Rtn ($)
    Realised Rtn ($)
    Realised Rtn (%)” col_tcell_cell_align_horz=”right” _builder_version=”4.14.5″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/dvmd_table_maker_item][dvmd_table_maker_item col_label=”Values” col_content=”-
    –
    2,220
    2,220
    25.23″ col_tcell_cell_align_horz=”right” _builder_version=”4.14.5″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/dvmd_table_maker_item][/dvmd_table_maker]

    Recommendation History

    Exit remaining shares

    by | Feb 1, 2022

    With the number of covid-19 cases in NSW and around the country starting to drop off, the ACL share price is beginning to retreat. So it is time to sell the remaining shares and lock in profits before earnings are reported in the next few weeks. The company has been a...

    First profit target reached – 50% of position closed

    by | Dec 23, 2021

    In early trading today the ACL share price reached an all-time high of $6.10. The first profit target to sell 50% of the high conviction’s reports position being 1,000 shares at $5.95 was reached. As a result, we sold 1,000 shares locking in a nice profit on part of...

    Upgrade – Change to profit target and stop-loss

    by | Dec 21, 2021

    This morning Australian Clinical Labs (ACL) released positive news upgrading its Revenue and Net Profit After Tax (NPAT). The company now expects Total revenue of between $497.3M to $517.2MNPAT of between $116.3M and $128.0M The upgrade, as expected, is because of...

    Share This